Abstract

During the H1N1 (swine flu) pandemic of 2009, the World Health Organization (WHO) confirmed more than 14,000 deaths globally; this included a death toll of 147 in Iran. In order to evaluate (a) the appropriateness of the Oseltamivir dose through calculation of a patient’s creatinine clearance (CrCl) and (b) the quality of data in the medical charts, we conducted a retrospective study at the Shariati Hospital in Tehran. All admissions to the hospital between the dates 1 October 2009 and 31 January 2010 were evaluated, amounting to a total of 51 patients’ charts, including 8 outpatient charts. Of these 51 charts, 26 (51%) contained all the information necessary to evaluate the CrCl. However, there was at least one piece of information missing (e.g. the patient’s weight; serum creatinine) from each of the remaining 25 charts (49% of the sample), which made it impossible for us to evaluate the dose. These results demonstrate how crucially important it is to ensure that all the necessary patient information is correctly registered at the time of admission in order to minimise medication errors.

Links

Aggregator Full Text

Authors

Hanafi S, Hayatshahi A, Torkamandi H, Javadi MR

Institution

Tehran University of Medical Sciences, Pharmaceutical Care Department, Dr. Shariati Hospital, Tehran, Iran. somayeh_hanafi@yahoo.com

Source

The HIM journal 41:1 2012 pg 31-5

MeSH

Antiviral Agents
Female
Humans
Influenza A Virus, H1N1 Subtype
Influenza, Human
Iran
Male
Medical Audit
Middle Aged
Oseltamivir
Pandemics
Questionnaires
Retrospective Studies

Pub Type(s)

Evaluation Studies
Journal Article

Language

eng

PubMed ID

22754968